CR9649A - Aminopirimidinas como modulares de cinasa - Google Patents
Aminopirimidinas como modulares de cinasaInfo
- Publication number
- CR9649A CR9649A CR9649A CR9649A CR9649A CR 9649 A CR9649 A CR 9649A CR 9649 A CR9649 A CR 9649A CR 9649 A CR9649 A CR 9649A CR 9649 A CR9649 A CR 9649A
- Authority
- CR
- Costa Rica
- Prior art keywords
- compounds
- aminopirimidins
- cinase
- modular
- trkb
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 abstract 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 3
- 101000932478 Homo sapiens Receptor-type tyrosine-protein kinase FLT3 Proteins 0.000 abstract 2
- 101150056950 Ntrk2 gene Proteins 0.000 abstract 2
- 102100020718 Receptor-type tyrosine-protein kinase FLT3 Human genes 0.000 abstract 2
- 230000002062 proliferating effect Effects 0.000 abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 108090000412 Protein-Tyrosine Kinases Proteins 0.000 abstract 1
- 102000004022 Protein-Tyrosine Kinases Human genes 0.000 abstract 1
- 102000016971 Proto-Oncogene Proteins c-kit Human genes 0.000 abstract 1
- 108010014608 Proto-Oncogene Proteins c-kit Proteins 0.000 abstract 1
- -1 aminopyrimidine compounds Chemical class 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/48—Two nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Rheumatology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Reproductive Health (AREA)
- Physical Education & Sports Medicine (AREA)
- Ophthalmology & Optometry (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pain & Pain Management (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicinal Preparation (AREA)
- Materials For Medical Uses (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
La invencion esta dirigida a compuestos de aminopirimidina de formula I: en donde R3, B, Z, r y R1 son como se definen en la presente, el uso de dichos compuestos como moduladores de proteina tirosina cinasa, en particular inhibidores de FLT3 y/o c Kit y/o TrkB en una celula o un sujeto, y el uso de dichos compuestos para prevenir o tratar en un sujeto un transtorno proliferativo celular y/o trastornos relacionados con FLT3 y/o c-kit y/o TrkB; la presente invencion esta dirigida ademas a composiciones farmaceuticas que comprenden los compuestos de la presente invencion, y a metodos para tratar condiciones tales como canceres y otros trastornos proliferativos celulares.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US68971505P | 2005-06-10 | 2005-06-10 | |
| US75108305P | 2005-12-16 | 2005-12-16 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CR9649A true CR9649A (es) | 2008-09-09 |
Family
ID=36930537
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CR9649A CR9649A (es) | 2005-06-10 | 2008-01-09 | Aminopirimidinas como modulares de cinasa |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US20070021435A1 (es) |
| EP (1) | EP1898917B1 (es) |
| JP (1) | JP2008545797A (es) |
| KR (1) | KR20080026592A (es) |
| AR (1) | AR054388A1 (es) |
| AT (1) | ATE420646T1 (es) |
| AU (1) | AU2006258039A1 (es) |
| BR (1) | BRPI0611597A2 (es) |
| CA (1) | CA2611495A1 (es) |
| CR (1) | CR9649A (es) |
| DE (1) | DE602006004873D1 (es) |
| EA (1) | EA200800018A1 (es) |
| EC (1) | ECSP077994A (es) |
| ES (1) | ES2319574T3 (es) |
| GT (1) | GT200600253A (es) |
| IL (1) | IL187686A0 (es) |
| MX (1) | MX2007015742A (es) |
| NI (1) | NI200700313A (es) |
| NO (1) | NO20080161L (es) |
| PE (1) | PE20070111A1 (es) |
| TW (1) | TW200716118A (es) |
| UY (1) | UY29591A1 (es) |
| WO (1) | WO2006135719A1 (es) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060281755A1 (en) * | 2005-06-10 | 2006-12-14 | Baumann Christian A | Synergistic modulation of flt3 kinase using aminopyrimidines kinase modulators |
| US20090306038A1 (en) * | 2005-09-13 | 2009-12-10 | Carceller Gonzalez Elena | 2-Aminopyrimidine derivatives as modulators of the histamine H4 receptor activity |
| MX2009008981A (es) | 2007-03-02 | 2009-09-02 | Genentech Inc | Prediccion de respuesta a un inhibidor her. |
| WO2013113719A1 (en) | 2012-02-03 | 2013-08-08 | Basf Se | Fungicidal pyrimidine compounds ii |
| WO2013113782A1 (en) | 2012-02-03 | 2013-08-08 | Basf Se | Fungicidal pyrimidine compounds |
| WO2013113773A1 (en) | 2012-02-03 | 2013-08-08 | Basf Se | Fungicidal pyrimidine compounds |
| WO2013113781A1 (en) | 2012-02-03 | 2013-08-08 | Basf Se | Fungicidal pyrimidine compounds i |
| IN2014DN07224A (es) | 2012-02-03 | 2015-04-24 | Basf Se | |
| CA2862354A1 (en) | 2012-02-03 | 2013-08-08 | Basf Se | Fungicidal pyrimidine compounds |
| WO2013113791A1 (en) | 2012-02-03 | 2013-08-08 | Basf Se | Fungicidal pyrimidine compounds |
| WO2013113776A1 (en) | 2012-02-03 | 2013-08-08 | Basf Se | Fungicidal pyrimidine compounds |
| WO2013113716A1 (en) | 2012-02-03 | 2013-08-08 | Basf Se | Fungicidal pyrimidine compounds |
| WO2013135672A1 (en) | 2012-03-13 | 2013-09-19 | Basf Se | Fungicidal pyrimidine compounds |
| IN2014DN07954A (es) | 2012-03-13 | 2015-05-01 | Basf Se | |
| CA3129665A1 (en) | 2019-03-21 | 2020-09-24 | Onxeo | A dbait molecule in combination with kinase inhibitor for the treatment of cancer |
| KR20220098759A (ko) | 2019-11-08 | 2022-07-12 | 인쎄름 (엥스띠뛰 나씨오날 드 라 쌍떼 에 드 라 흐쉐르슈 메디깔) | 키나제 억제제에 대해 내성을 획득한 암의 치료 방법 |
| WO2021148581A1 (en) | 2020-01-22 | 2021-07-29 | Onxeo | Novel dbait molecule and its use |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1206265B1 (en) * | 1999-06-30 | 2003-11-12 | Merck & Co., Inc. | Src kinase inhibitor compounds |
| WO2003026665A1 (en) * | 2001-09-26 | 2003-04-03 | Bayer Pharmaceuticals Corporation | 2-phenylamino-4-(5-pyrazolylamino)-pyrimidine derivatives as kinase inhibitors, in particular, src kinase inhibitors |
-
2006
- 2006-06-06 US US11/422,366 patent/US20070021435A1/en not_active Abandoned
- 2006-06-07 CA CA002611495A patent/CA2611495A1/en not_active Abandoned
- 2006-06-07 EA EA200800018A patent/EA200800018A1/ru unknown
- 2006-06-07 AT AT06772650T patent/ATE420646T1/de not_active IP Right Cessation
- 2006-06-07 JP JP2008515951A patent/JP2008545797A/ja not_active Withdrawn
- 2006-06-07 ES ES06772650T patent/ES2319574T3/es not_active Expired - Lifetime
- 2006-06-07 AU AU2006258039A patent/AU2006258039A1/en not_active Abandoned
- 2006-06-07 BR BRPI0611597-7A patent/BRPI0611597A2/pt not_active IP Right Cessation
- 2006-06-07 EP EP06772650A patent/EP1898917B1/en not_active Expired - Lifetime
- 2006-06-07 MX MX2007015742A patent/MX2007015742A/es unknown
- 2006-06-07 DE DE602006004873T patent/DE602006004873D1/de not_active Expired - Fee Related
- 2006-06-07 NI NI200700313A patent/NI200700313A/es unknown
- 2006-06-07 KR KR1020087000220A patent/KR20080026592A/ko not_active Withdrawn
- 2006-06-07 WO PCT/US2006/022411 patent/WO2006135719A1/en not_active Ceased
- 2006-06-08 PE PE2006000639A patent/PE20070111A1/es not_active Application Discontinuation
- 2006-06-08 UY UY29591A patent/UY29591A1/es unknown
- 2006-06-08 GT GT200600253A patent/GT200600253A/es unknown
- 2006-06-09 AR ARP060102427A patent/AR054388A1/es not_active Application Discontinuation
- 2006-06-09 TW TW095120480A patent/TW200716118A/zh unknown
-
2007
- 2007-11-27 IL IL187686A patent/IL187686A0/en unknown
- 2007-12-10 EC EC2007007994A patent/ECSP077994A/es unknown
-
2008
- 2008-01-09 NO NO20080161A patent/NO20080161L/no not_active Application Discontinuation
- 2008-01-09 CR CR9649A patent/CR9649A/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO2006135719A1 (en) | 2006-12-21 |
| AR054388A1 (es) | 2007-06-20 |
| KR20080026592A (ko) | 2008-03-25 |
| AU2006258039A1 (en) | 2006-12-21 |
| HK1116059A1 (en) | 2008-12-19 |
| MX2007015742A (es) | 2008-04-29 |
| ATE420646T1 (de) | 2009-01-15 |
| IL187686A0 (en) | 2008-08-07 |
| GT200600253A (es) | 2007-01-12 |
| ES2319574T3 (es) | 2009-05-08 |
| PE20070111A1 (es) | 2007-02-09 |
| EP1898917B1 (en) | 2009-01-14 |
| ECSP077994A (es) | 2008-01-23 |
| JP2008545797A (ja) | 2008-12-18 |
| NI200700313A (es) | 2009-03-24 |
| DE602006004873D1 (de) | 2009-03-05 |
| TW200716118A (en) | 2007-05-01 |
| NO20080161L (no) | 2008-01-28 |
| UY29591A1 (es) | 2006-10-02 |
| EA200800018A1 (ru) | 2008-06-30 |
| US20070021435A1 (en) | 2007-01-25 |
| CA2611495A1 (en) | 2006-12-21 |
| EP1898917A1 (en) | 2008-03-19 |
| BRPI0611597A2 (pt) | 2010-09-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ECSP077994A (es) | Aminopirimidinas como moduladores de cinasa | |
| CR9647A (es) | Moduladores de cinasa de aminoquinolina y amoniquinazolina | |
| CR9652A (es) | Moduladores de alquilquinolina y alquilquinazolina cinasa | |
| ECSP077991A (es) | Aminopirimidinas como moduladores de cinasa | |
| NI200800179A (es) | Triazolopiridazinas como moduladores de la tirosina cinasa | |
| CR9650A (es) | Derivados de tienopirimidina y tienopiridina como inhibidores de tirosina cinasa 3 tipo fms | |
| GT200600143A (es) | Fenilacetamidas apropiadas como inhibidores de la proteina kinasa | |
| ECSP088558A (es) | Carbonilamino pirrolopirazoles, potentes inhibidores de quinasa | |
| UY30942A1 (es) | Nuevos derivados de 3-([1,2,4,]triazolo[4,3-a]piridin-7-il)benzamida | |
| CU20070160A7 (es) | Pirrolopirazoles, inhibidores potentes de quinasa | |
| ECSP088561A (es) | Derivados de pirimidinil-aril-urea que son inhibidores de fgf | |
| ECSP109953A (es) | Derivados de piridazinona | |
| UY30748A1 (es) | Compuesto0s novedosos | |
| EA201070395A1 (ru) | Ингибиторы polo-подобных киназ | |
| GT200600035A (es) | Aminopiridinas como inhibidores de beta-secretasa | |
| MXPA04002042A (es) | Compuestos de bencimidazol sustituidos y su uso para el tratamiento del cancer. | |
| CR11391A (es) | Derivados 1,2,4-triazol amino como moduladores de mglur5 | |
| CR20110082A (es) | Nuevos inhibidores de la proteina tirosina quinasa y receptores vegf-2 y uso farmacéutico de los mismos | |
| EA200702136A1 (ru) | Композиции станнсопорфина и их применение | |
| UY29592A1 (es) | Aminopirimidinas como moduladores de quinasas | |
| UY29587A1 (es) | Moduladores de aminoquinolina y aminoquinazolina quinasa | |
| CR9238A (es) | Pirrolopirazoles, potentes inhibidores de cinasa |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal (granting procedure) |